轩竹生物-B：每股发售价11.6港元 香港公开发售获4908.33倍认购

Core Points - Xuan Zhu Bio-B (02575) announced the results of its share allocation, with a total of 67.335 million H-shares globally offered [1] - The offering consisted of 10% for public sale in Hong Kong and 90% for international sale [1] - The final offer price was set at HKD 11.6 per share, raising approximately HKD 701 million in net proceeds from the global offering [1] - Each board lot consists of 500 shares, and trading of the H-shares is expected to commence on October 15, 2025, at 9:00 AM Hong Kong time [1] - The Hong Kong public offering was oversubscribed by 4,908.33 times, while the international offering was oversubscribed by 10.15 times [1]